相关实验视频
Updated: Jul 6, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
基于结构的药物发现,以确定SARS-CoV2尖端蛋白-ACE2相互作用抑制剂
Ravi Kant1, Rahul Kaushik2,3, Madhu Chopra4
1Medical Biotechnology Laboratory, Dr. B. R. Ambedkar Center for Biomedical Research &Delhi School of Public Health, IoE, University of Delhi, Delhi, India.
黄素通过阻断Spike蛋白之间的相互作用,有效地抑制了诸如Delta和Omicron之类的SARS-CoV-2变体.
科学领域:
- 病毒学和计算药物发现 病毒学和计算药物发现
背景情况:
- 严重急性呼吸系统综合征冠状病毒-2 (SARS-CoV-2) 演变为关注的变种 (VOC),如三角形和Omicron.
- 这些挥发性有机化合物表现出改变了对人类血管酶转化酶2 (hACE2) 的结合亲和力.
研究的目的:
- 调查黄素作为SARS-CoV-2变种的潜在抑制剂.
- 为了评估黄素对三角形和欧米克朗变种的疗效,与spike蛋白与hace2的相互作用.
主要方法:
- 计算方法包括分子对接和分子动力学 (MD) 模拟.
- 对VOCs的受体结合域 (RBD ((S1)) 中突变的分析.
主要成果:
- 与其他化合物相比,黄素在对抗Delta和Omicron变种方面表现出更高的抑制效率.
- 德尔塔和欧米克朗RBD中的突变改变了Spike蛋白结构和 hACE2结合.
- 分子对接和MD模拟证实了Curcumin-Spike蛋白质复合物的稳定性.
结论:
- 黄素显示出作为对抗SARS-CoV-2变种的治疗剂的显著潜力.
- 建议进行进一步的体内研究,以验证黄素的治疗效果.
更多相关视频
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
相关概念视频
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Protein-protein Interfaces
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...